The ability of gallamine, metocurine, pancuronium, tubocurarine and atropinc to block the response to postganglionic stimulation of the vagus nerve were measured in isolated, spontaneously beating guineapig atria. From analysis of the results in conjunction with those of earlier assays of concentrations that block effects of preganglionic vagal stimulation, it was concluded that only tubocurarine possessed ganglionic blocking activity. From calculation of the extent of block of muscarinic receptors at drug concentrations which blocked the response to postganglionic vagal stimulation, it was concluded that gallamine and pancuronium have an antivagal action exerted most probably on the postganglionic nerve terminal, and that this action is the most likely explanation of the tachycardia seen clinically with these two drugs.
sites. There are known examples of all three types of action, including occlusion of muscarinic receptors by atropine and interference with ganglionic transmission by hexamethonium. The presynaptic terminal as a site of drug action has been postulated frequently in connection with action of drugs at the neuromuscular junction (Riker, 1975) .
The vagal system might be activated at three points: preganglion, postganglion, or at the muscarinic receptor ( fig. 1 ). iDrug influences on the response to presynaptic stimulation and to receptor activation were examined in two previous studies (Lee Son and Waud, 1977, 1978) . The present experiments were designed to complement these studies and to use the three set of results to identify the relative contribution of blockade at these three sites of action in the production of tachycardia. Presynaptic stimulation and receptor stimulation were easily obtained. In the former case electric stimulation was applied to the vagal trunk (Lee Son and Waud, 1978) . Receptor activation was achieved by administration of the muscarinic agonist carbachol (Lee Son and Waud, 1977) . Stimulation of the postganglionic fibres-so crucial to distinguishing ganglionic effects from effects at the terminal nerve ending-is more difficult to do; the postganglionic fibres are embedded in the atrial muscle. Thus any electrical shock applied to these fibres will also be applied to the heart muscle. In the present study the nerve fibres were activated selectively by timing the stimulus pulses so that they occurred during the refractory period of the heart muscle (see below).
The above experimental design can be summarized in terms of how various experimental results would be interpreted. (1) Interference with The quantitative aspects of applying these principles is described in the discussion.
Experimental
Guineapigs of either sex weighing 250-500 g were killed by a blow on the head and the right atrium was excised rapidly. The vagus nerve was severed near the heart leaving just the vagal fibres within the atrial muscle, including the parasympathetic ganglion cells and the postganglionic nerve fibres. The atrium was suspended in Krebs' solution at 36 °C, which was bubbled with oxygen 95% and carbon dioxide 5%. A pair of external recording electrodes was used to sense surface electrical activity of the spontaneously beating preparation ( fig. 2 ). This signal was used to monitor automaticity by measuring the interval between beats and to trigger a train of impulses used to produce field stimulation. To this end, a pair of stimulating electrodes was placed in the bath, one on either side of the tissue. A voltage applied to these electrodes drove current through both the muscle and nerve cells in the preparation. A pulse generator producing supramaximal pulses of 0.3 ms duration, at a frequency of 100 Hz was used to deliver a train of impulses for field stimulation. This train was timed to come during the refractory period of the atrial muscle cells. Since the refractory period of a nerve is much shorter than that of the cardiac muscle, the nerve will have recovered while the muscle was still refractory. Thus it was possible to stimulate nerve fibres and not the muscle by delivering a train of impulses during this interval. The number of impulses per train was varied from 1 to 9.
Such "field" stimulation produced a transient increase in the interval between beats. This interval increased as the number of impulses per train was increased ( fig. 3 ). Thus a graph relating interval between beats to train length could be generated. After the control relationship had been established, a neuromuscular blocking agent or atropine was added to the bath and the response to field stimulation redetermined. Finally, the drug was washed out and a third train length-response curve was obtained to confirm reversibility of drug effect ( fig. 4) . The effect of the addition of either one of the neuromuscular blocking agents or atropine was to "scale down" the train length-interval curves; that is, for any given train length, the change in interval between beats was reduced by roughly the same proportional amount. Therefore the fractional depression of the response was averaged over the nine train lengths to yield an objective measure of the effect of each of the drugs. Graded concentrations of the neuromuscular blocking agents and atropine produced graded effects and dose-response curves could be constructed by plotting antagonism to field stimulation against concentration of antagonist ( fig. 5 ). From these curves, ED 50 values for block of the effect of field stimulation, "FB SO " values, were obtained (from an iterative non-linear least squares fitting process which also yielded a value for the standard error of the estimate of FB 50 . The statistical procedure was analogous to that reported earlier from this laboratory (Waud, 1975) ). 
RESULTS AND DISCUSSION
Gallamine, metocurine, pancuronium and tubocurarine all depressed the response to field stimulation in a dose-dependent fashion. Figure 4 gives an example of the results obtained and figure 5 summarizes the dose-response relationship for the agents studied. The FB J0 values obtained are listed in table I. Also included for comparison are "VB 50 " values, the concentration blocking preganglionic vagal stimulation by 50% (Lee Son and Waud, 1978) and estimates of the apparent dissociation constant, K B at the cholinergic receptors of the atrial pacemaker (Lee Son and Waud, 1977) .
The method of field stimulation developed for this study has proved both powerful and convenient. Sympathetic nerve fibres also lie in the preparation and can be activated by field stimulation (Blinks, 1967) . However, we have found that parasympathetic endings can be selectively activated by not stimulating the preparation during every beat, as Blinks did, but by using only a single train of pulses and examining the succeeding interval between beats. Apparently, the response to stimulation of parasympathetic nerve fibres develops more rapidly than that to sympathetic activation. In fact, there seems to be no detectable contribution from the sympathetic system in the present study since propranolol was without effect on the relationship between train length and interval between succeeding beats. Because parasympathetic activation can be selectively achieved by appropriate choice of stimulating parameters and without use of "pharmacological tools," interpretation of the results is not clouded by the possibility of contributions from any drugs in the system other than that being examined.
Absolute drug concentrations have no pharmacological significance. With the neuromuscular blocking agents the concentration effective at the (Lee Son and Waud, 1977) . Thus clinical neuromuscular block would involve concentrations of about 0.96 umol litre" 1 for tubocurarine, 0.50 umol litre" 1 for dimethyltubocurarine, 0.22 umol litre" 1 for pancuronium and 4.12 umol litre" 1 for gallamine. Thus, for example when we see in figure 5 and table I that it requires roughly 150 umol litre" 1 of tubocurarine to block field stimulation, we can conclude the drug would produce no block at this anatomical level when given clinically.
The measure of field stimulation used, FB J0 , is an arbitrarily chosen endpoint. Similarly, VB J0 values previously obtained also involve no absolute standard. Thus a frame of reference is needed for comparison of drug effects on pre-and postganglionic stimulation. Atropine provides such a measure. The site of block with atropine is common to the pathway of signal transmission for both pre-and postganglionic vagal stimulation. Therefore, the ratio of VB 5O /FB 5O for atropine represents the value expected from a drug which exerts no differential effect on pre-v. postganglionic stimulation, that is a drug not acting at ganglia. Table I shows that this ratio is 2.9 for atropine. For comparison, figure 6 shows the effect of hexamethonium on the system. VB J0 was about 60 umol litre" 1 , whereas hexamethonium 100 umol litre" l produced negligible block of field stimulation, that is the FB 50 was considerably greater than 100 umol litre"
1 . Thus the ratio VB J0 /FB J0 would be much less than unity. The neuromuscular blocking agents can now be examined against this background. The values of 3.57, 1.88 and 1.44 seen with gallamine, pancuronium and metocurine respectively were of the same order of magnitude as that seen with atropine. On the other hand, tubocurarine blocked responses to preganglionic stimulation more selectively than did atropine. The value of VB 30 /FB J0 was 0.29, less than unity as seen also with hexamethonium and reflecting the well known ganglionic blocking activity of tubocurarine (Hughes and Chappie, 1976) .
The absence of a vagal ganglionic blocking action of gallamine and pancuronium means one must look peripheral to the ganglion to find the site of the vagal blocking action of these agents observed previously (Lee Son and Waud, 1978 Tubocurarine gives values indistinguishable from those for atropine, indicating that this neuromuscular blocking agent has no effect on the response to field stimulation beyond that which would be expected from its (weak) ability to block muscarinic receptors. On the other hand, gallamine, pancuronium and metocurine leave roughly three to five times as many receptors free when they are at their FB SO concentrations. This means they are blocking field stimulation by some mechanism beyond a simple atropine-like receptor occlusion. The site of this effect must be peripheral to the ganglionic synapse and proximal to the muscarinic receptor. The postganglionic axon and the nerve terminal thereof are two potential sites of action in this interval. The latter, the nerve ending, seems a more likely candidate since appreciable local anaesthetic activity has not been found with competitive neuromuscular blocking agents (Jarcho et al., 1950; Riker and Wescoe, 1951; Buckett et al., 1968) . The nerve terminal action is not clinically significant in the case of metocurine since it occurs at concentrations too great to be likely to occur clinically. However, this presynaptdc action appears to be the best candidate to explain the tachycardia seen with gallamine and pancuronium.
A presynaptdc site of action of drugs is not without ample precedent (Langer, 1974; Riker, 1975) . Of particular interest is the adrenergic terminal where analogues of noradrenaline depress transmitter output (Berthelsen and Pettinger, 1977) . In this context, it is not surprising that quaternary nitrogen compounds might similarly interfere with release at a cholinergic nerve ending. It has also been suggested that clonidine, which acts at the presynaptic alpha-adrenergic receptor, might also act on a presynaptic receptor to inhibit release of transmitter from cholinergic fibres (Werner, Starke and Schumann, 1972) . However, the relationship of this phenomenon to the presynaptic action seen in the present study is not clear. At present the experiments only reveal that the presynaptic effect exists, and do not shed light on its mechanism.
